Lucid Diagnostics (LUCD) Competitors

Butterfly Network (NYSE:BFLY) and Lucid Diagnostics (NASDAQ:LUCD) are both small-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their institutional ownership, dividends, risk, earnings, analyst recommendations, media sentiment, valuation and profitability.

Do institutionals & insiders believe in BFLY or LUCD?

37.9% of Butterfly Network shares are held by institutional investors. Comparatively, 74.0% of Lucid Diagnostics shares are held by institutional investors. 25.2% of Butterfly Network shares are held by company insiders. Comparatively, 6.8% of Lucid Diagnostics shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Do analysts rate BFLY or LUCD?

Butterfly Network presently has a consensus price target of $3.50, indicating a potential upside of 94.99%. Lucid Diagnostics has a consensus price target of $3.55, indicating a potential upside of 225.69%. Given Lucid Diagnostics' stronger consensus rating and higher possible upside, analysts clearly believe Lucid Diagnostics is more favorable than Butterfly Network.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Butterfly Network	0 Sell rating(s)	0 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	3.00
Lucid Diagnostics	0 Sell rating(s)	0 Hold rating(s)	4 Buy rating(s)	1 Strong Buy rating(s)	3.20

Does the media refer more to BFLY or LUCD?

In the previous week, Lucid Diagnostics had 4 more articles in the media than Butterfly Network. MarketBeat recorded 8 mentions for Lucid Diagnostics and 4 mentions for Butterfly Network. Butterfly Network's average media sentiment score of 0.67 beat Lucid Diagnostics' score of 0.35 indicating that Butterfly Network is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Butterfly Network	1 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Lucid Diagnostics	1 Very Positive mention(s)	1 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	1 Very Negative mention(s)	Neutral

Which has more risk & volatility, BFLY or LUCD?

Butterfly Network has a beta of 2.46, meaning that its stock price is 146% more volatile than the S&P 500. Comparatively, Lucid Diagnostics has a beta of 1.23, meaning that its stock price is 23% more volatile than the S&P 500.

Which has higher valuation & earnings, BFLY or LUCD?

Lucid Diagnostics has lower revenue, but higher earnings than Butterfly Network. Butterfly Network is trading at a lower price-to-earnings ratio than Lucid Diagnostics, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Butterfly Network	$82.06M	5.41	-$72.49M	-$0.29	-6.19
Lucid Diagnostics	$4.35M	27.11	-$45.53M	-$1.34	-0.81

Is BFLY or LUCD more profitable?

Butterfly Network has a net margin of -75.56% compared to Lucid Diagnostics' net margin of -1,699.86%. Lucid Diagnostics' return on equity of 0.00% beat Butterfly Network's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Butterfly Network	-75.56%	-29.97%	-21.13%
Lucid Diagnostics	-1,699.86%	N/A	-124.27%

Summary

Lucid Diagnostics beats Butterfly Network on 10 of the 17 factors compared between the two stocks.